Azenta Inc
$ 27.38
-1.79%
26 Feb - close price
- Market Cap 1,284,195,000 USD
- Current Price $ 27.38
- High / Low $ 28.12 / 26.79
- Stock P/E 48.07
- Book Value 37.26
- EPS 0.58
- Next Earning Report 2026-05-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.01 %
- ROE 0.02 %
- 52 Week High 45.26
- 52 Week Low 23.91
About
Azenta Inc. is a premier provider of sample management solutions and life science tools, driving efficiency and precision in laboratory operations for the biotechnology and pharmaceutical industries. The company is at the forefront of innovation, offering automated solutions, biorepository services, and advanced storage technologies that empower clients to expedite drug discovery while ensuring regulatory compliance. With a strong emphasis on cutting-edge technology and collaboration with customers, Azenta is strategically positioned to leverage growth opportunities in the expanding global life sciences market. Its commitment to enhancing scientific research through state-of-the-art products further solidifies its competitive advantage in the dynamic fields of biobanking and sample management.
Analyst Target Price
$38.67
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-04 | 2025-11-11 | 2025-08-05 | 2025-05-07 | 2025-02-05 | 2024-11-12 | 2024-08-06 | 2024-05-08 | 2024-02-07 | 2023-11-13 | 2023-08-08 | 2023-05-09 |
| Reported EPS | 0.09 | 0.21 | 0.19 | 0.05 | 0.08 | 0.18 | 0.16 | 0.05 | 0.02 | 0.13 | 0.13 | -0.06 |
| Estimated EPS | 0.1364 | 0.2 | 0.14 | 0.07 | 0.06 | 0.11 | 0.07 | 0.02 | -0.03 | 0.02 | -0.02 | -0.02 |
| Surprise | -0.0464 | 0.01 | 0.05 | -0.02 | 0.02 | 0.07 | 0.09 | 0.03 | 0.05 | 0.11 | 0.15 | -0.04 |
| Surprise Percentage | -34.0176% | 5% | 35.7143% | -28.5714% | 33.3333% | 63.6364% | 128.5714% | 150% | 166.6667% | 550% | 750% | -200% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-11 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.1529 |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | None | None | None | None | None | None | None | None | None | None |
| Amount | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AZTA
2026-02-18 05:57:53
KeyBanc has reiterated a Sector Weight rating on Azenta, Inc. (NASDAQ:AZTA) following the Society for Laboratory Automation and Screening 2026 Conference, noting positive signals for the life science sector despite the stock's 36.97% decline over the past year. The company recently showcased its BioArc Ultra automated storage system and reported mixed Q1 2026 earnings with a revenue beat but an EPS miss, prompting TD Cowen to lower its price target. Azenta is also advancing space research through a partnership with Frontier Space.
2026-02-17 13:58:09
KeyBanc has reiterated a Sector Weight rating on Azenta, Inc. following positive signals for the life science sector observed at a recent conference, despite the stock's 36.97% decline over the past year. The company showcased its BioArc Ultra automated storage system at a sold-out pre-conference event. Recent financial results showed an EPS miss but a revenue beat for Q1 2026, leading TD Cowen to lower its price target due to declining gross margins, while Azenta also partnered with Frontier Space for the EGGS-2 mission.
2026-02-16 07:28:08
Azenta, Inc. (Nasdaq: AZTA) announced its management will participate in the Stephens Annual Investment Conference in Nashville, Tennessee, on November 15-16, 2023. The company will host a presentation on November 16, 2023, at 11:00 am CT, with a live webcast available on its investor relations website. Azenta is a global provider of life sciences solutions, offering cold-chain sample management and multiomics services for drug development and clinical research.
2026-02-14 21:57:29
AlphaQuest LLC significantly reduced its stake in Azenta, Inc. (NASDAQ:AZTA) by 91.8% in Q3, selling 47,738 shares and retaining 4,240 shares valued at $122,000. This comes as Azenta missed EPS expectations but exceeded revenue forecasts in its latest quarter, while analysts generally rate the stock as "Hold" with a consensus price target of $41.33. The company has also authorized a $250 million share buyback program.
2026-02-14 21:57:29
Caprock Group LLC has acquired a new stake of 53,707 shares in Azenta, Inc. (NASDAQ:AZTA) valued at approximately $1.64 million during the third quarter, representing 0.12% ownership. Azenta's board has also authorized a $250 million share buyback program, indicating management's view that the stock may be undervalued despite missing consensus on its latest EPS report. Analysts currently have an average "Hold" rating on Azenta with a price target of $41.33.
2026-02-13 23:27:58
Azenta, Inc. (NasdaqGS:AZTA) has partnered with Frontier Space to test its sample management technologies in microgravity for space-based life sciences research. This collaboration could validate Azenta's solutions for demanding environments and provide new reference points for biopharma, academic, and government customers. Investors are watching how this high-profile testing ground, along with the company's valuation metrics, will impact its future earnings and market position.
